Terms: = Endocrine gland cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL AND Treatment
63 results:
1. International consensus on mitotane treatment in pediatric patients with adrenal cortical tumors: indications, therapy, and management of adverse effects.
Riedmeier M; Antonini SRR; Brandalise S; Costa TEJB; Daiggi CM; de Figueiredo BC; de Krijger RR; De Sá Rodrigues KE; Deal C; Del Rivero J; Engstler G; Fassnacht M; Fernandes Luiz Canali GC; Molina CAF; Gonc EN; Gültekin M; Haak HR; Guran T; Hendriks Allaird EJ; Idkowiak J; Kuhlen M; Malkin D; Meena JP; Pamporaki C; Pinto E; Puglisi S; Ribeiro RC; Thompson LDR; Yalcin B; Van Noesel M; Wiegering V
Eur J Endocrinol; 2024 Mar; 190(4):G15-G24. PubMed ID: 38552173
[TBL] [Abstract] [Full Text] [Related]
2. Predicting the chemosensitivity of pancreatic cancer cells as a personalized therapy.
Rudno-Rudzińska J; Michel O; Płochocki M; Kulbacka J
Adv Clin Exp Med; 2022 Sep; 31(9):1049-1053. PubMed ID: 36135813
[TBL] [Abstract] [Full Text] [Related]
3. Feasibility of a large multi-center translational research project for newly diagnosed breast and ovarian cancer patients with affiliated biobank: the BRandO biology and outcome (BiO)-project.
De Gregorio A; Nagel G; Möller P; Rempen A; Schlicht E; Fritz S; Flock F; Kühn T; Thiel F; Felberbaum R; Ebner F; De Gregorio N; Friedl TWP; Wiesmüller L; Kuhn P; Schmitt M; Janni W; Rothenbacher D; Huober J
Arch Gynecol Obstet; 2020 Jan; 301(1):273-281. PubMed ID: 31781887
[TBL] [Abstract] [Full Text] [Related]
4. Dual-drug loaded micelle for combinatorial therapy targeting HIF and mTOR signaling pathways for ovarian cancer treatment.
Doddapaneni BS; Al-Fatease AM; Rao DA; Alani AWG
J Control Release; 2019 Aug; 307():272-281. PubMed ID: 31260753
[TBL] [Abstract] [Full Text] [Related]
5. Neuroendocrine Breast Carcinomas Share Prognostic Factors with Gastroenteropancreatic Neuroendocrine Tumors: A Putative Prognostic Role of Menin, p27, and SSTR-2A.
Roininen N; Takala S; Haapasaari KM; Jukkola-Vuorinen A; Mattson J; Heikkilä P; Karihtala P
Oncology; 2019; 96(3):147-155. PubMed ID: 30282082
[TBL] [Abstract] [Full Text] [Related]
6. Presymptomatic Identification of cancers in Pregnant Women During Noninvasive Prenatal Testing.
Amant F; Verheecke M; Wlodarska I; Dehaspe L; Brady P; Brison N; Van Den Bogaert K; Dierickx D; Vandecaveye V; Tousseyn T; Moerman P; Vanderstichele A; Vergote I; Neven P; Berteloot P; Putseys K; Danneels L; Vandenberghe P; Legius E; Vermeesch JR
JAMA Oncol; 2015 Sep; 1(6):814-9. PubMed ID: 26355862
[TBL] [Abstract] [Full Text] [Related]
7. Cellular therapy in combination with cytokines improves survival in a xenograft mouse model of ovarian cancer.
Ingersoll SB; Ahmad S; McGann HC; Banks RK; Stavitzski NM; Srivastava M; Ali G; Finkler NJ; Edwards JR; Holloway RW
Mol Cell Biochem; 2015 Sep; 407(1-2):281-7. PubMed ID: 26048718
[TBL] [Abstract] [Full Text] [Related]
8. Multipronged, strategic delivery of paclitaxel-topotecan using engineered liposomes to ovarian cancer.
Jain A; Jain SK
Drug Dev Ind Pharm; 2016 Jan; 42(1):136-149. PubMed ID: 26006330
[TBL] [Abstract] [Full Text] [Related]
9. Pancreatic cancer, treatment options, and GI-4000.
Hartley ML; Bade NA; Prins PA; Ampie L; Marshall JL
Hum Vaccin Immunother; 2015; 11(4):931-7. PubMed ID: 25933185
[TBL] [Abstract] [Full Text] [Related]
10. Pancreatic cancer, treatment options, and GI-4000.
Hartley ML; Bade NA; Prins PA; Ampie L; Marshall JL
Hum Vaccin Immunother; 2014; 10(11):3347-53. PubMed ID: 25585100
[TBL] [Abstract] [Full Text] [Related]
11. Oxaliplatin and ototoxicity: is it really safe for hearing?
Yüce S; Seker MM; Koç S; Uysal IO; Kaçan T; Doğan M; Doğan M; Babacan NA; Kiliçkap S
Turk J Med Sci; 2014; 44(4):586-9. PubMed ID: 25551926
[TBL] [Abstract] [Full Text] [Related]
12. Paradigm shift in the surgical management of multigland parathyroid hyperplasia: an individualized approach.
Lebastchi AH; Donovan PI; Udelsman R
JAMA Surg; 2014 Nov; 149(11):1133-7. PubMed ID: 25188005
[TBL] [Abstract] [Full Text] [Related]
13. Antitumor effects of baculovirus-infected dendritic cells against human pancreatic carcinoma.
Fujihira A; Suzuki T; Chang MO; Moriyama T; Kitajima M; Takaku H
Gene Ther; 2014 Sep; 21(9):849-54. PubMed ID: 25009006
[TBL] [Abstract] [Full Text] [Related]
14. Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites.
Jennings VA; Ilett EJ; Scott KJ; West EJ; Vile R; Pandha H; Harrington K; Young A; Hall GD; Coffey M; Selby P; Errington-Mais F; Melcher AA
Int J Cancer; 2014 Mar; 134(5):1091-101. PubMed ID: 23982804
[TBL] [Abstract] [Full Text] [Related]
15. Gemcitabine in patients with intraductal papillary mucinous neoplasm with an associated invasive carcinoma of the pancreas.
Otsuka T; Morizane C; Nara S; Ueno H; Kondo S; Shimada K; Kosuge T; Ikeda M; Hiraoka N; Okusaka T
Pancreas; 2013 Jul; 42(5):889-92. PubMed ID: 23695798
[TBL] [Abstract] [Full Text] [Related]
16. Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation.
Mete O; Asa SL
Mod Pathol; 2011 Dec; 24(12):1545-52. PubMed ID: 21804527
[TBL] [Abstract] [Full Text] [Related]
17. Review article: enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer.
Imrie CW; Connett G; Hall RI; Charnley RM
Aliment Pharmacol Ther; 2010 Nov; 32 Suppl 1():1-25. PubMed ID: 21054452
[TBL] [Abstract] [Full Text] [Related]
18. Solitary adrenal metastasis from invasive ductal breast cancer: an uncommon finding.
Liu XJ; Shen P; Wang XF; Sun K; Sun FF
World J Surg Oncol; 2010 Jan; 8():7. PubMed ID: 20105336
[TBL] [Abstract] [Full Text] [Related]
19. Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.
Brydøy M; Oldenburg J; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Hauge ER; Dahl O; Fosså SD
J Natl Cancer Inst; 2009 Dec; 101(24):1682-95. PubMed ID: 19940282
[TBL] [Abstract] [Full Text] [Related]
20. Multi-centric pancreatic cancer without PanIN lesion.
Naito Y; Eriguchi N; Kume T; Naito M; Nishimura M; Ohdo M; Itai N; Hayashida S; Naito H; Arikawa S; Ureshino H; Yasumoto M; Kusano H; Yano H
J Hepatobiliary Pancreat Surg; 2009; 16(5):699-703. PubMed ID: 19333539
[TBL] [Abstract] [Full Text] [Related]
[Next]
